Search This Blog

Tuesday, May 7, 2019

Biohaven Pharmaceutical reports Q1 EPS ($1.41), consensus ($1.48)

Cash as of March 31 was $217.4M, compared to $264.2M as of December 31, 2018.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)